LCO 4402 \\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01011-R02-
SB.docx
1 of 3
General Assembly Raised Bill No. 1011
January Session, 2021
LCO No. 4402
Referred to Committee on PUBLIC SAFETY AND SECURITY
Introduced by:
(PS)
AN ACT CONCERNING TH E USE OF OPIOID ANTAGONISTS AND
EPINEPHRINE CARTRIDG E INJECTORS BY POLICE OFFICERS.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
Section 1. (NEW) (Effective from passage) (a) As used in this section, (1) 1
"epinephrine cartridge injector" has the same meaning as provided in 2
section 19a-909 of the general statutes; (2) "law enforcement unit" and 3
"police officer" have the same meanings as provided in section 7-294a of 4
the general statutes; and (3) "opioid antagonist" has the same meaning 5
as provided in section 17a-714a of the general statutes. 6
(b) Each law enforcement unit shall (1) require its police officers to 7
receive training in the use of an opioid antagonist and an epinephrine 8
cartridge injector, and (2) acquire and maintain a supply of opioid 9
antagonists and epinephrine cartridge injectors for use by its police 10
officers when responding to a medical emergency. 11
(c) Any police officer who completes such training shall be permitted 12
to carry and administer (1) an opioid antagonist to an individual whom 13
the officer believes in good faith is experiencing an opioid-related drug 14 Raised Bill No. 1011
LCO 4402 {\\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01011-
R02-SB.docx }
2 of 3
overdose, and (2) an epinephrine cartridge injector to an individual 15
whom the officer believes in good faith is experiencing anaphylaxis. 16
Sec. 2. Section 52-557v of the general statutes is repealed and the 17
following is substituted in lieu thereof (Effective from passage): 18
(a) A person (1) employed to work for the state or any political 19
subdivision thereof that has acquired and maintains a supply of 20
epinephrine cartridge injectors, (2) who is trained in the use of an 21
epinephrine cartridge injector in accordance with subdivision (2) of 22
subsection (a) of section 19a-909 or section 1 of this act, and (3) provides 23
or administers an epinephrine cartridge injector to an individual whom 24
the person believes in good faith is experiencing anaphylaxis during the 25
course of such person's employment, shall not be liable to such 26
individual for civil damages or subject to criminal prosecution for any 27
personal injuries that result from acts or omissions by such person in 28
using an epinephrine cartridge injector, which may constitute ordinary 29
negligence. The immunity provided in this subsection shall not apply to 30
wilful or wanton misconduct or acts or omissions constituting gross 31
negligence. 32
(b) The state or any political subdivision thereof that (1) has acquired 33
and maintains a supply of epinephrine cartridge injectors, and (2) 34
employs a person who (A) is trained in the use of an epinephrine 35
cartridge injector in accordance with subdivision (2) of subsection (a) of 36
section 19a-909 or section 1 of this act, and (B) provides or administers 37
an epinephrine cartridge injector to an individual whom the person 38
believes in good faith is experiencing anaphylaxis during the course of 39
such person's employment, shall not be liable to such individual for civil 40
damages for any personal injuries that result from acts or omissions by 41
such person in using an epinephrine cartridge injector, which may 42
constitute ordinary negligence. The immunity provided in this 43
subsection shall not apply to wilful or wanton misconduct or acts or 44
omissions constituting gross negligence. 45 Raised Bill No. 1011
LCO 4402 {\\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01011-
R02-SB.docx }
3 of 3
This act shall take effect as follows and shall amend the following
sections:
Section 1 from passage New section
Sec. 2 from passage 52-557v
PS Joint Favorable
APP Joint Favorable